Nam, G Kang, TW Shin, JH Choi, KI 2024-01-21T03:38:06Z 2024-01-21T03:38:06Z 2021-09-02 2006-02-01 0960-894X https://pubs.kist.re.kr/handle/201004/135757 The synthesis and anti-Helicobacter pylori (H. pylori) activity evaluation of a new series of erythromycin A (E)-9-oxime ether derivatives are described. These compounds exhibited comparable in vitro anti-H. pylori activity and improved acid stability compared to the reference compound clarithromycin. (c) 2005 Elsevier Ltd. All rights reserved. English PERGAMON-ELSEVIER SCIENCE LTD ANTIBACTERIAL ACTIVITY CHEMICAL MODIFICATION O-METHYLATION CLARITHROMYCIN ROXITHROMYCIN OXIME ACID Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives Article 10.1016/j.bmcl.2005.10.045 1 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.16, no.3, pp.569 - 572 BIOORGANIC & MEDICINAL CHEMISTRY LETTERS 16 3 569 572 scie scopus 000234641000017 2-s2.0-29644436528 Chemistry, Medicinal Chemistry, Organic Pharmacology & Pharmacy Chemistry Article ANTIBACTERIAL ACTIVITY CHEMICAL MODIFICATION O-METHYLATION CLARITHROMYCIN ROXITHROMYCIN OXIME ACID anti-Helicobacter pylori erythromycin oxime ether MIC acid stability